| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020158 |
| Receipt No. | R000023285 |
| Official scientific title of the study | Efficacy of the shortening procedure time and safety under sufficient counter traction using Endoscopic Ring Thread Technique (ERTT) |
| Date of disclosure of the study information | 2015/12/10 |
| Last modified on | 2018/12/11 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Efficacy of the shortening procedure time and safety under sufficient counter traction using Endoscopic Ring Thread Technique (ERTT) | |
| Title of the study (Brief title) | Efficacy of the ERTT | |
| Region |
|
|
| Condition | |||||
| Condition | The inclusion criteria of this study's patients who satisfied the following expanded indication inclusion criteria for ESD according to the guidelines of the Japan Gastric Cancer Association
(JGCA) were included. In differentiated gastric cancers, intramucosal carcinoma has no size restriction, whereas intramucosal carcinoma accompanied by ulcer scar and SM1 carcinoma (500 um from the muscularis mucosae) should be <30 mm. In undifferentiated carcinomas, intramucosal carcinoma should be <20 mm. Included patients consented to the study after receiving oral and written explanations. |
||||
| Classification by specialty |
|
||||
| Classification by malignancy | Malignancy | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | During gastric endoscopic submucosal dissection, the clear surgical view is necessary to perform the procedure safely.Under clear view using ERTT enable us to perform ESD without bleeding and perforation. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Others |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The procedure time of ESD between ERTT group and conventionalgroup |
| Key secondary outcomes | 1.Bleeding during ESD
2.The procerure time of creating ERTT 3.Evaluation of visibility of ERTT using VAS (visual analogue sysytem) score |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Innovative endoscopic counter traction method called ERTT which was made of surgical thread like ring-shaped thread | |
| Interventions/Control_2 | Conventional ESD | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The inclusion criteria of this study's patients who satisfied the following expanded indication inclusion criteria for ESD according to the guidelines of the Japan Gastric Cancer Association
(JGCA) were included. In differentiated gastric cancers, intramucosal carcinoma has no size restriction, whereas intramucosal carcinoma accompanied by ulcer scar and SM1 carcinoma (500 um from the muscularis mucosae) should be <30 mm. In undifferentiated carcinomas, intramucosal carcinoma should be <20 mm. Included patients consented to the study after receiving oral and written explanations. |
|||
| Key exclusion criteria | Patients who should be removed the lesion by operation | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Mori Hirohito |
| Organization | Kagawa university |
| Division name | Department of Gastroenterology and Neurology |
| Address | 1750-1, Miki, Kida, Kagawa, Japan |
| TEL | 087-891-1256 |
| hiro4884@med.kagawa-u.ac.jp | |
| Public contact | |
| Name of contact person | Hayashi Yukari |
| Organization | Ehime Rousai Hospital |
| Division name | Medical Affairs Division |
| Address | 13-27, Minamikomatsubara, Niihama, Ehime 792-8550, Japan |
| TEL | 0897-33-6191 |
| Homepage URL | |
| ijikachou@ehimerosai.jp | |
| Sponsor | |
| Institute | Kagawa university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ehime rousai hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023285 |